Welcome to
Epitope.us


Epitope Announces Management Change

    BEAVERTON, Ore., June 3 /PRNewswire/ -- Epitope, Inc. (Nasdaq: EPTO) today
announced that Adolph J. Ferro, Ph.D., will devote full time to his position
as president and chief executive officer of the company's Agritope group,
effective immediately.  W. Charles Armstrong, a member of the board of
directors, will serve as interim president and chief executive officer of
Epitope, Inc.
    "Management and the board have been discussing strategies for accelerating
Agritope's development as a stand-alone enterprise," Dr. Ferro stated.  "I
look forward to turning my full attention to guiding Agritope in its
transition from development-stage company to mature business."
    Dr. Ferro was a co-founder of Agricultural Genetic Systems, Inc., which
the company acquired in 1987 and renamed Agritope, Inc.  He is a co-inventor
of Agritope's patented ethylene-control technology.  Agritope is developing
applications of the technology to control ripening in fruits and vegetables.
    Roger Pringle, chairman of the board, praised Dr. Ferro's accomplishments.
"Al has done an outstanding job of keeping Epitope fully funded in the face of
regulatory delays and other hurdles that prevented it from relying on product
revenues.  Now that our medical products are generating meaningful sales, we
are pleased that Al will devote his efforts to commercializing Agritope's
genetic technology, which he was instrumental in developing."
    The company will immediately initiate a search for a new president and
chief executive officer of Epitope, Inc.  Mr. Armstrong, who will succeed Dr.
Ferro in that capacity on an interim basis, has been a director of Epitope
since 1989.  He is the former chief executive officer of Bank of America
Oregon.
    Mr. Pringle stated that the management change is part of a long-range plan
to allow the company's Epitope Medical Products and Agritope groups to operate
independently.  The company's board of directors continues to consider a
proposal to issue a second, separate class of common stock that would track
the performance of Agritope.  The board also plans to consider alternatives
that could involve a spin-off or other divestiture of Agritope.
    Epitope, Inc. is a biotechnology company that develops and markets medical
diagnostic products through its Epitope Medical Products group.  Its Agritope
group is focused on the development and commercialization of novel
agricultural products using plant genetic engineering and other modern

Source: EPITOPE Inc.


Content of this page is copyright and reprinted here for educational and historical information.
Copyright 2004 - 2018 - Ekim Notnud - All rights Reserved
This site is an unofficial historical site and not affiliated with Epitope, Inc.


  Click for Heirloom Tomato Seed Selection Victory Seed Company Save Seeds - Victory Horticultural Library